Patients First: Reducing Stigma and Applying Harm Reduction - Part I Collaboration

November 7, 2019 - November 6, 2020

Target Audience: 

Only open to Alberta pharmacists registered with the Alberta College of Pharmacy. 


This session will benefit any pharmacist regardless of their practice setting.



This presentation explores some issues pharmacists might face related to substance use and harm reduction. This harm reduction focused program is aimed at helping pharmacists learn about collaboration strategies to assist in the building and maintenance of professional relationships with patients requiring harm reduction measures and how to foster interdisciplinary collaboration. As well, you will learn about the role of the pharmacist in the context of harm reduction.



Laura D. Evans  MD C.CSAM, D.ABAM, C.SIAM 

Dr. Laura Evans is an addiction medicine specialist working in addiction medicine with Alberta Health Services and at various community locations within Calgary. She is also a Canadian Society of Addiction Medicine (CSAM) Board member. She holds the following credentials: Diplomate American Board of Addiction Medicine, Cert. International Society of Addiction Medicine, Cert. Canadian Society of Addiction Medicine, Clinical Assistant Professor Dept. Family Medicine University of Calgary.


Essi Salokangas  BScPharm  

Essi is a clinical pharmacist with a passion for improving health outcomes in vulnerable populations using evidence-based practice, empathy, and humor. A U of A 2016 pharmacy alumni, Essi went on to co-found the Adherence & Community Engagement (ACE) Team, a pharmacist-led, interdisciplinary outreach team for complex patients in Edmonton, Alberta. She is now the first clinical pharmacist on the Addiction Recovery and Community Health (ARCH) Team, addiction consult service for patients with substance use disorder and social inequity, at the Royal Alexandra Hospital.



  1. Define stigma
  2. Define harm reduction
  3. Explore the role of the pharmacist in the context of reducing stigma, building relationships, and implementing harm reduction
  4. Describe the pivotal role of the pharmacist in collaborating to reduce harm for individuals in acute care and community settings.
  5. Reflect on the unique perspective to teams that pharmacists have in providing harm reduction care
  6. Identify opportunities where the pharmacist can add value and avoid pitfalls



CCCEP Program #: 8007-2019-2925-I-P

Expires: November 6, 2020

CEU’s:  1.0

Attendees will receive a Statement of Attendance following the successful completion of the post-exam.  A score of 70% or greater is required on the post-exam.



Registration for this course will grant you access to the presentation and materials for a period of 90 days.  Please ensure you complete the course within 90 days of registering.



RxA Member Fee:             $ 0.00 (no charge)

Non-member Fee:            $75.00

The value of this course is $100.00


Please contact the Alberta Pharmacists' Association at if you have questions about this session.


Cancellation and Refunds: 
Not applicable. 


RxE-MEMBER AdvantageTM program for Non-Members included in your registration fee.

Every Non-Member that registers for this program will receive a $50.00 RxE-MEMBER AdvantageTM credit* that they can use towards the purchase of their RxA membership for the NEXT membership year.  This incentive is part of a program RxA is offering to encourage all pharmacists to become a member of RxA.  

For more about the RxE-MEMBER AdvantageTM program click here. 


Difficulty Registering Online? 

We'll process it the next business day and you'll receive a confirmation by e-mail. 


Only open to Alberta pharmacists registered with the Alberta College of  Pharmacy  

Member Fee:  $0.00
Student Fee:  $0.00
Non-Member Fee:  $75.00